```html

Depressive Psychosis – A Comprehensive Medical Guide

Overview

Depressive psychosis (also called psychotic depression) is a severe form of major depressive disorder (MDD) in which the classic symptoms of depression are accompanied by psychotic features such as delusions or hallucinations. It is not a separate disorder; rather, it is a subtype of depression that requires both mood‑focused and antipsychotic treatment.

• Who it affects: Adults of any age, but the average onset is in the late 30s to early 50s. Women are diagnosed slightly more often than men (≈55% of cases).
• Prevalence: Psychotic features occur in roughly 10–15% of people with major depression. That translates to about 1–2 % of the general population.
• Impact: The condition carries a higher risk of suicide (up to 20 % lifetime risk) and often results in greater functional impairment than non‑psychotic depression.

Symptoms

Symptoms fall into two categories: depressive symptoms (present in all major depressions) and psychotic symptoms (unique to the psychotic subtype).

Depressive Symptoms

• Persistent sadness or hopelessness – most days for ≥2 weeks.
• Loss of interest or pleasure (anhedonia) in previously enjoyed activities.
• Significant weight change – usually loss, but sometimes gain.
• Sleep disturbances – insomnia or hypersomnia.
• Fatigue or loss of energy even after trivial tasks.
• Feelings of worthlessness or excessive guilt, often unrealistic.
• Difficulty concentrating or making decisions.
• Recurrent thoughts of death or suicide, which are more common in the psychotic form.

Psychotic Symptoms

• Delusions – fixed false beliefs that are often mood‑congruent (e.g., “I am worthless and will ruin everyone’s life”). They can also be bizarre.
• Hallucinations – sensory experiences without external stimulus. Auditory (hearing voices that criticize or command) is most common; visual or tactile hallucinations occur less frequently.
• Paranoid ideas – believing others intend to harm or betray you.
• Catatonic features (rare) – immobility, mutism, or purposeless agitation.

Both sets of symptoms usually appear together, and the psychotic features tend to be more severe when the depressive mood is at its worst.

Causes and Risk Factors

The exact cause is multifactorial, involving an interplay of biological, psychological, and social elements.

Biological Factors

• Neurotransmitter dysregulation – decreased serotonin, norepinephrine, and dopamine activity.
• HPA‑axis hyperactivity – chronic stress leads to excess cortisol, which can damage hippocampal neurons.
• Genetics – first‑degree relatives of individuals with psychotic depression have a 2‑3× higher risk (heritability ≈40 %).
• Brain‑structure changes – MRI studies show reduced volume in the prefrontal cortex and amygdala.
• Inflammation – elevated cytokines (e.g., IL‑6, TNF‑α) have been linked to both depression and psychosis.

Psychological & Social Factors

• History of severe or chronic stress (e.g., abuse, bereavement).
• Early‑life trauma, especially emotional neglect.
• Substance misuse (especially alcohol, cannabis, stimulants).
• Social isolation, unemployment, or financial hardship.

Who Is at Higher Risk?

• Individuals with a prior episode of major depression.
• People with bipolar disorder who have experienced depressive phases.
• Those with a family history of psychotic disorders (schizophrenia, schizoaffective).
• Elderly adults – psychotic features are more common in late‑life depression.

Diagnosis

Diagnosing depressive psychosis requires careful clinical evaluation. No single laboratory test confirms the condition, but tests help rule out medical mimics.

Clinical Assessment

1. Structured interview – using DSM‑5 criteria for Major Depressive Episode with psychotic features.
2. Mental status exam – assesses appearance, speech, mood, thought content (delusions, hallucinations), cognition, and insight.
3. Risk assessment – suicidal ideation, self‑harm plans, or risk to others.

Laboratory and Imaging Tests

• Basic labs: CBC, CMP, thyroid‑stimulating hormone (TSH), vitamin B12, folate – to exclude endocrine or metabolic causes.
• Urine toxicology – screen for substances that can provoke psychosis.
• Neuroimaging (MRI or CT) – indicated if an organic brain disorder (tumor, stroke) is suspected.

Diagnostic Criteria (DSM‑5)

Five (or more) of the nine depressive symptoms must be present for ≥2 weeks **and** at least one of the following psychotic features must be observed:

• Delusional thinking (often mood‑congruent).
• Auditory or other sensory hallucinations.

Symptoms must cause clinically significant distress or impairment and not be attributable to substances or another medical condition.

Treatment Options

Effective management typically combines pharmacotherapy, psychotherapy, and, when needed, somatic treatments. Early, aggressive treatment is recommended because of the high risk of suicide.

Medication

• Antidepressants – First‑line agents are selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs). Example: sertraline 50–200 mg daily.
• Antipsychotics – Second‑generation agents (e.g., quetiapine, olanzapine, risperidone) are added to target delusions/hallucinations. Quetiapine 300–600 mg is FDA‑approved for depressive psychosis.
• Combination therapy – Many clinicians start both classes simultaneously (“dual therapy”) to achieve faster remission.
• ECT (Electroconvulsive Therapy) – Highly effective, especially for severe, medication‑resistant cases or when rapid response is needed (e.g., imminent suicide risk).
• Other options – Intravenous ketamine or esketamine, and, in refractory cases, transcranial magnetic stimulation (TMS).

Psychotherapy

• Cognitive‑Behavioral Therapy (CBT) – Addresses negative thought patterns and helps patients challenge delusional beliefs.
• Supportive therapy – Provides emotional support and coping strategies.
• Family psychoeducation – Improves adherence and reduces caregiver burden.

Lifestyle and Adjunctive Strategies

• Regular aerobic exercise (150 min/week) – boosts endorphins and neuroplasticity.
• Consistent sleep‑wake schedule – improves mood regulation.
• Balanced diet rich in omega‑3 fatty acids, vitamins D and B12.
• Mind‑body practices (mindfulness, yoga) – decrease anxiety and rumination.
• Avoid alcohol and illicit drugs, which can worsen psychosis.

Monitoring & Follow‑up

Patients should be seen weekly for the first month, then every 2–4 weeks, with attention to medication side effects, weight, metabolic labs (glucose, lipids), and suicidality.

Living with Depressive Psychosis

Managing day‑to‑day life while coping with depressive psychosis involves practical steps that empower patients and reduce relapse risk.

Medication Management

• Use a pill organizer or medication‑reminder app.
• Never abruptly stop antipsychotics or antidepressants without consulting a provider.
• Report new or worsening side effects promptly.

Building a Support System

• Identify trusted friends or family members who can check in regularly.
• Join a support group for mood disorders or psychosis (in‑person or online).
• Consider a crisis plan with your clinician outlining who to call if symptoms intensify.

Daily Structure

1. Morning routine – light exposure, brief activity, medication.
2. Scheduled meals – balanced nutrition to stabilise mood.
3. Planned activities – work, hobbies, or volunteer tasks to maintain purpose.
4. Evening wind‑down – limit screens, practice relaxation, and adhere to a consistent bedtime.

Managing Psychotic Thoughts

• Label them as “symptoms” rather than facts.
• Use grounding techniques (e.g., the 5‑4‑3‑2‑1 sensory method).
• Write down delusional content and discuss it in therapy—often the irrational nature becomes clearer on paper.

Safety Precautions

• Remove or secure firearms, sharp objects, or large quantities of medication.
• Keep a “safety phone” list with crisis‑line numbers (e.g., 988 in the U.S., Samaritans 116 123 in the UK).

Prevention

While we cannot guarantee prevention, several strategies reduce the likelihood of a first episode or recurrence.

• Early treatment of depression – Prompt therapy or medication after initial depressive symptoms appear.
• Stress‑management programs – Mindfulness‑based stress reduction (MBSR) or resilience training.
• Regular medical follow‑up – Particularly for chronic medical conditions (thyroid disease, diabetes) that can mimic or exacerbate mood symptoms.
• Screening in high‑risk groups – Family history, prior psychotic depression, or bipolar spectrum disorders warrant closer monitoring.
• Healthy lifestyle – Exercise, adequate sleep, balanced nutrition, and avoidance of substance abuse.

Complications

If untreated, depressive psychosis can lead to serious medical, psychological, and social consequences.

• Suicide – The leading cause of death, with estimates of up to 20 % lifetime risk.
• Self‑harm or accidental injury due to impaired judgment.
• Chronic functional decline – Inability to maintain employment, relationships, or independent living.
• Substance use disorder as patients self‑medicate.
• Medical complications – Poor nutrition, neglect of chronic illnesses, and increased cardiovascular risk from antipsychotic side effects.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institute of Mental Health (NIMH), World Health Organization (WHO), Cleveland Clinic, American Psychiatric Association DSM‑5, JAMA Psychiatry, Lancet Psychiatry.

```